Christina Jenkins

Co-Founder & General Partner at Convergent Ventures

Speaker

Christina Jenkins, MD (“CJ”) is a venture investor, adviser, and board member who uses technology and trusted relationships to improve health, at scale. Her expertise spans clinical medicine, health systems, and health plans, and she applies her unique perspective to enable value generation.

Dr. Jenkins is a Co-Founder and General Partner of Convergent Ventures and leads its health and life sciences investing strategy. She focuses on Seed/A teams building AI-enabled platforms and products from drug discovery through to human diagnosis, therapy, and monitoring. She is a board member of Biotia, Noze, and Tensor Bio.

She is an independent board member of PE-backed companies Help at Home and Medical Solutions. She is an advisory board member of Independence Health Group (parent of Independence Blue Cross and AmeriHealth Caritas), and a National Advisor (subject matter expert) to Manatt Health, advising C-suite leaders in provider and life sciences organizations.

Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals, the nation’s largest public hospital system. There, she recruited and led a team of 130 in a $1.2B effort to implement tech-enabled care models and accelerate value-based payment readiness for 1M lives.

Dr. Jenkins earned her B.S. in Industrial Management at Purdue University and her M.D. from Northwestern University. She was a board-certified Clinical Instructor of Medicine at Mount Sinai Medical Center in New York, where she also completed her residency. She is a member of the Kauffman Fellows, a global leadership program in venture capital. Prior to medical school, Dr. Jenkins was an analyst (FMP) for GE Healthcare.